Page 1

9/19/24 , 2:41 PM Achilles Therapeutics Reports First Quarter 2021 Financial Results and Recent Business Highlights | Achilles Therapeutics plc ACHILLES THERAPEUTICS PRESS RELEASE Achilles Therapeutics Reports First Quarter 2021 Financial Results and Recent Business Highlights May 11 2021 - Reported first clinical data from the CHIRON and THETIS trials and received recommendation from the Independent Data Safety Monitoring Committee to continue trials as planned - - Completed initial public offering of ADSS raising $ 175.5 million in gross proceeds - LONDON , May 11 , 2021 ( GLOBE NEWSWIRE ) -- Achilles Therapeutics plc ( NASDAQ : ACHL ) , a clinical - stage biopharmaceutical company developing precision T cell therapies to treat solid tumors , today announced its financial results for the first quarter ended March 31 , 2021 and recent business highlights . " Achilles made significant progress in the first quarter of 2021. We reported the first clinical data from our ongoing CHIRON and THETIS trials evaluating our precision TIL cNeT therapy in patients with non - small cell lung cancer and melanoma , respectively , and priced our successful US initial public offering on Nasdaq , which closed just after quarter - end , " said https://ir.achillestx.com/news-releases/news-release-details/achilles-therapeutics-reports-first-quarter-2021-financial 1/6